Clinical Trial Update: The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the supplementary effects of Agaricus blazei Murill extract on Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Agaricus blazei Murill extract

Snippet

Sponsor: ECbiotech Taiwan | Conditions: Diabetes Mellitus, Type II | Phase 3 | Status: COMPLETED